Blood and tissue collection for head and neck cancers
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study collects blood and tissue samples from people with cancers of the head, neck, or upper airway to learn how the immune system responds to these cancers. The goal is to find better ways to treat these diseases in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or may have a cancer of the head, neck, throat, or upper airway/digestive tract (like the voice box, tonsils, or esophagus).
- You are willing and able to sign a consent form to take part in the study.
- You do not have a bleeding disorder or other condition that makes a tissue biopsy dangerous.
- You do not have a heart or breathing condition that makes a lung exam (bronchoscopy) unsafe.
- You can read and fill out forms in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to deeply analyze immune cells and tumor cells in the blood and tumors of cancer patients. It may help researchers better understand how the immune system interacts with cancer.
This study looks at what makes some cancers more “noticeable” to the immune system. It may help researchers design better future immunotherapy by collecting information (often including blood samples) from people with different cancers.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study collects blood and tumor tissue samples from patients with certain untreated cancers to help researchers develop and improve tests. You may be eligible if you have one of the listed cancer types and have not yet started treatment.
This study looks for early “biomarkers” (signals in blood or tissue) to see how well head and neck cancer treatments are working over time. It may help doctors adjust treatment sooner based on those early signals.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.